Capital Fund Management (CFM)
CPRX

Capital Fund Management (CFM)’s Catalyst Pharmaceutical CPRX Stock Holding History

Capital Fund Management (CFM)’s Portfolio CPRX Stock Details CPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-116,183
Closed -$2.29M – 2406
2025
Q3 		$2.29M Buy
116,183
+36,112
+45% +$743K 0.01% 1720
2025
Q2 		$1.74M Buy
80,071
+7,737
+11% +$183K ﹤0.01% 1750
2025
Q1 		$1.75M Sell
72,334
-51,122
-41% -$1.15M 0.01% 1471
2024
Q4 		$2.58M Sell
123,456
-9,123
-7% -$196K 0.01% 1386
2024
Q3 		$2.64M Buy
132,579
+6,492
+5% +$120K 0.01% 1306
2024
Q2 		$1.95M Sell
126,087
-131,448
-51% -$2.05M 0.01% 1395
2024
Q1 		$4.11M Buy
257,535
+6,316
+3% +$95.2K 0.01% 1142
2023
Q4 		$4.22M Sell
251,219
-117,250
-32% -$1.6M 0.01% 1169
2023
Q3 		$4.31M Buy
368,469
+44,063
+14% +$589K 0.01% 1011
2023
Q2 		$4.36M Buy
324,406
+12,656
+4% +$182K 0.02% 899
2023
Q1 		$5.17M Buy
311,750
+197,016
+172% +$3.25M 0.02% 726
2022
Q4 		$2.13M Buy
114,734
+87,576
+322% +$1.35M 0.01% 914
2022
Q3 		$348K Sell
27,158
-33,668
-55% -$399K ﹤0.01% 1334
2022
Q2 		$426K Buy
+60,826
New +$446K ﹤0.01% 1278
2020
Q4 		– Sell
-144,063
Closed -$428K – 1322
2020
Q3 		$428K Buy
144,063
+23,793
+20% +$93K 0.01% 1074
2020
Q2 		$556K Buy
+120,270
New +$540K 0.01% 860
2020
Q1 		– Sell
-24,725
Closed -$93K – 1620
2019
Q4 		$93K Buy
+24,725
New +$116K ﹤0.01% 1781

Other funds holding CPRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Capital Fund Management (CFM)'s CPRX Position: Q4 2025 in Review

Capital Fund Management (CFM) sold out of Catalyst Pharmaceutical (CPRX) in Q4 2025, closing a stake of 116,183 shares — an estimated $2.29M sold.

Capital Fund Management (CFM) first reported a position in CPRX in Q4 2019 and held it in 17 quarters. The position peaked at $5.17M in Q1 2023. 373 funds tracked by Wall St. Rank hold CPRX as of Q4 2025.

  • Capital Fund Management (CFM) reported no remaining Catalyst Pharmaceutical position as of Q4 2025 after selling out during the quarter.
  • Capital Fund Management (CFM) sold 116,183 Catalyst Pharmaceutical shares in Q4 2025, an estimated $2.29M.
  • Capital Fund Management (CFM) first reported a position in Catalyst Pharmaceutical in Q4 2019 and held it in 17 quarters.
  • Capital Fund Management (CFM)'s Catalyst Pharmaceutical position peaked at $5.17M in Q1 2023.
  • 373 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q4 2025.

Based on Capital Fund Management (CFM)'s 13F filing for Q4 2025, filed 17 Feb 2026.